(Q43885631)

27 November 2017

title

Case control study of prognostic markers and disease outcome in inflammatory carcinoma breast: a unique clinical experience (English)

1 reference

27 November 2017

Aziz SA

1

1 reference

27 November 2017

Pervez S

2

1 reference

27 November 2017

Khan S

3

1 reference

27 November 2017

Kayani N

4

1 reference

27 November 2017

Azam SI

5

1 reference

27 November 2017

Rahbar MH

6

1 reference

27 November 2017

publication date

1 November 2001

1 reference

27 November 2017

1 reference

27 November 2017

volume

7

1 reference

27 November 2017

issue

6

1 reference

27 November 2017

page(s)

398-404

1 reference

Inflammatory carcinoma of the breast: the case for conservatism

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2001.07604.X

Epidemiologic features of rapidly progressing breast cancer in Tunisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2001.07604.X

Power calculations for matched case-control studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2001.07604.X

Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2001.07604.X

Inflammatory breast cancer and body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2001.07604.X

High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.2001.07604.X

10.1046/J.1524-4741.2001.07604.X

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference